ITC Votes to Institute Investigation on Reduced Folate Nutraceuticals
The International Trade Commission voted to institute an investigation of certain reduced folate nutraceutical products and l-methylfolate raw ingredients used therein. The products at issue in this investigation are nutraceutical products that contain reduced folates.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
The investigation is based on a complaint filed by South Alabama Medical Science Foundation of Mobile, Ala.; Merck & Cie of Switzerland; and Pamlab LLC of Covington, La., on Sept. 10, 2012. The complaint alleges violations of Section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain reduced folate nutraceutical products and l-methylfolate raw ingredients used therein that infringe patents asserted by the complainants. The complainants request that the ITC issue an exclusion order and cease and desist orders.
The ITC has identified the following as respondents in this investigation:
- Gnosis SpA of Italy;
- Gnosis Bioresearch SA of Switzerland;
- Gnosis USA Inc. of Doylestown, PA; and
- Macoven Pharmaceuticals LLC of Magnolia, TX.
(See ITT's Online Archives 12091137 for summary of the original complaint, and 12082219 for summary of ITC's request for comments relating to the complaint.)